Table 2. The effect of randomised maternal treatment on antibody concentrations among infants at one year of age.
| Antibody concentrations | Geometric mean | Geometric mean ratio (95% CI)* | Geometric mean | Geometric mean ratio (95% CI)* | ||
|---|---|---|---|---|---|---|
| Albendazole | Placebo | Praziquantel | Placebo | |||
| HiB (g/ml) | 0.89 | 0.78 | 1.14 (0.93–1.39) | 0.8 | 0.87 | 0.92 (0.75–1.13) |
| Diphtheria (Dtox IU/ml) | 0.03 | 0.03 | 1.07 (0.94–1.22) | 0.03 | 0.03 | 0.93 (0.82–1.05) |
| Hepatitis B (mIU/ml) | 99.94 | 97.27 | 1.03 (0.86–1.23) | 90.41 | 106.88 | 0.85 (0.71–1.01) |
| Pertussis toxin (Ptx EU/ml) | 10.78 | 9.02 | 1.20 (0.99–1.44) | 9.92 | 9.81 | 1.01 (0.84–1.21) |
| FHA (EU/ml) | 3.1 | 2.86 | 1.08 (0.97–1.21) | 2.99 | 2.97 | 1.01 (0.90–1.13) |
| Pertactin (Pm EU/ml) | 11.36 | 10.97 | 1.04 (0.91–1.17) | 10.96 | 11.36 | 0.96 (0.84–1.11) |
* Bias-corrected accelerated CIs computed by bootstrapping